Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
16.61
-0.39 (-2.29%)
At close: May 8, 2026, 4:00 PM EDT
16.52
-0.09 (-0.52%)
After-hours: May 8, 2026, 7:46 PM EDT

Viridian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-360.59-342.6-269.95-237.73-237.73-129.87
Depreciation & Amortization
0.460.460.540.520.520.26
Stock-Based Compensation
47.4744.342.1567.1767.1719.77
Other Adjustments
-8.97-1.58-14.66-4.71-4.710.05
Change in Receivables
-----0.35
Changes in Accounts Payable
9.436.56-0.07-12.04-12.0411.52
Changes in Accrued Expenses
8.4316.2121.344.725.017.72
Changes in Unearned Revenue
-0.07----0.29-0.29
Changes in Other Operating Activities
-2.360.26-11.67-2.11-2.11-3.34
Operating Cash Flow
-303.39-276.39-232.32-184.17-184.17-93.84
Capital Expenditures
-0.43-0.5-0.51-0.9-0.9-0.8
Purchases of Investments
-599.35-579.28-695.07-407.88-407.88-223.26
Proceeds from Sale of Investments
539.42542.21466.93314.53314.53108.94
Investing Cash Flow
-60.36-37.56-228.65-94.25-94.25-115.13
Long-Term Debt Issued
-28.88-15155
Net Long-Term Debt Issued (Repaid)
-28.88-15155
Issuance of Common Stock
67.38366.99459.68146.79146.79295.75
Net Common Stock Issued (Repurchased)
67.38366.99459.68146.79146.79295.75
Issuance of Preferred Stock
--2576.1976.1944
Net Preferred Stock Issued (Repurchased)
--2576.1976.1944
Other Financing Activities
-18.4530.88-26.94-12.32-12.32-22.51
Financing Cash Flow
423.89426.74457.74225.67225.67322.24
Net Cash Flow
60.13112.79-3.23-52.75-52.75113.28
Free Cash Flow
-303.82-276.89-232.83-185.07-185.07-94.64
FCF Margin
-428.42%-390.81%-77096.00%-58938.90%-10444.00%-3193.89%
Free Cash Flow Per Share
-3.38-3.27-3.43-4.14-5.77-7.94
Levered Free Cash Flow
-345.13-290.73-260.32-232.54-124.68-59.34
Unlevered Free Cash Flow
-370.24-340.4-289.41-264.25-144.11-64.66
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q